Pulse Biosciences, Inc.

NASDAQ:PLSE

Medical - Instruments & Supplies

Healthcare
$45.83 +3.83%

+$0.97 today

Market cap
$3.37B
Beta
1.66
P/E (TTM)
-24.0
EPS (TTM)
-$1.10
52W Low $12.56High $28.53

Volume 0.33M

Average 0.31M

PLSE Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Pulse Biosciences, Inc.NASDAQ: PLSE

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows, but more slowly than its trailing trend

Q2 FY2026 weighted avg shares of 69.2M shares rose 2.9% year over year, behind the +7.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 2.1% from the prior quarter. Over 3 fiscal years it compounded at +25.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +2.9% toward the trailing-twelve-month pace of +7.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
69.2M+2.1% QoQ
Last fiscal yearDec 2025
67.4M+15.4% YoY
LTMJun 2026
67.94M+7.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.9%——
1 year+15.4%——
3-year CAGR+25.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
67.4M USD
Year-over-year change
+15.4%
4-year CAGR
+24.6%

Weighted Avg Shares vs competitors

How PLSE compares with its peers on the latest reported figures

  • PLSE's LTM Jun 2026 weighted avg shares of 67.94M shares is the 5th highest of the 11 companies compared; the peer median is 50.45M shares.
  • Its year-over-year change of +7.1% is the 7th highest of 11, against a peer median of +8.7%.
  • Over three fiscal years its annual growth of +25.7% compares with a peer median of +13.3%.
PLSE Competitors Peer median
Weighted Avg Shares for PLSE and competitors
Company Period LTM YoY 3-year CAGR
OPKOPKO Health, Inc.LTM Mar 2026772.39M +8.0%+1.5%
ATAIAtai Beckley Inc.LTM Jun 2026289.46M +66.9%+13.3%
IMTXImmatics N.V.LTM Mar 2026125.95M +14.7%+22.1%
NVCRNovoCure LimitedLTM Mar 2026112.28M +3.5%+2.1%
PLSEPulse Biosciences, Inc.LTM Jun 202667.94M +7.1%+25.7%
KMTSKestra Medical Technologies, Ltd.LTM Jan 202651.26M +3.5%—
STAASTAAR Surgical CompanyLTM Apr 202649.63M +0.8%+1.1%
LFMDLifeMD, Inc.LTM Mar 202646.17M +9.5%+13.4%
DNTHDianthus Therapeutics, Inc.LTM Jun 202644.91M +27.5%+116.1%
BBNXBeta Bionics, Inc.LTM Mar 202643M +7.0%+100.9%
NKTRNektar TherapeuticsLTM Jun 202623.04M +64.4%+10.6%
Peer median (excluding PLSE) 50.45M+8.7%+13.3%

Competitors are the stored peer set for PLSE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.42M700K00350K
Cost of Revenue1.97M11.94M1.21M01.61M
Gross Profit(550K)(11.24M)(1.21M)0(1.26M)
Gross Margin-38.8%-1606.3%——-360.0%
Research & Development28.64M20.84M27.8M32.34M44.72M
Selling, General & Admin33.82M25.97M15.78M23.92M32.03M
Operating Expenses62.46M46.81M42.37M56.26M75.68M
Depreciation & Amortization1.15M1.36M1.21M1.18M1.07M
EBITDA(62.51M)(57.15M)(39.9M)(52.41M)(71.71M)
EBITDA Margin-4408.6%-8164.3%——-20488.6%
Operating Income(63.01M)(58.06M)(43.57M)(56.26M)(76.94M)
Operating Margin-4443.9%-8293.9%——-21982.6%
Interest Income002.46M2.67M4.21M
Interest Expense646K448K1.1M00
Other Income / Expenses(646K)(448K)1.36M2.67M4.16M
Income Before Tax(63.66M)(58.51M)(42.21M)(53.59M)(72.78M)
Pre-Tax Margin-4489.4%-8357.9%——-20794.6%
Income Tax Expense00000
Net Income(63.66M)(58.51M)(42.21M)(53.59M)(72.78M)
Net Margin-4489.4%-8357.9%——-20794.6%
EPS (Basic)(2.28)(1.72)(0.88)(0.92)(1.08)
EPS (Diluted)(2.28)(1.72)(0.88)(0.92)(1.08)
Weighted Avg Shares27.96M33.94M48.04M58.4M67.4M
Weighted Avg Shares (Diluted)27.96M33.94M48.04M58.4M67.4M

Pulse Biosciences, Inc.

NASDAQ:PLSE

Intrinsic Alpha fair value

Locked

Current Price

$45.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.